Citalopram induced torsade de pointes, a rare life threatening side effect

International Journal of Cardiology

Volumn 131, Issue 1, 2008, Pages

  Kanjanauthai, Somsupha ^a   Kanluen, Tony ^a   Chareonthaitawee, Panithaya ^b  

^a HENRY FORD HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acquired Long QT syndrome; Citalopram; Selective serotonin reuptake inhibitors; Torsade de pointes

Indexed keywords

CITALOPRAM; ISOPRENALINE; MAGNESIUM SULFATE;

AGED; ARTICLE; CASE REPORT; CHEMISTRY; DIZZINESS; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EMERGENCY WARD; HUMAN; LIFE; LONG QT SYNDROME; MALE; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; TELEMETRY; TORSADE DES POINTES; UNITED STATES; VITAL SIGN;

AGED, 80 AND OVER; CITALOPRAM; HUMANS; LONG QT SYNDROME; MALE; TORSADES DE POINTES;

EID: 56349148945     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.006     Document Type: Article

References (6)

1. Moss A.J. Long QT syndrome. JAMA 289 (2003) 2041
2. Jackman W.M., Friday K.J., Anderson J.L., et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 31 (1998) 115
3. El-Sherif N., and Turitto G. Torsade de pointes. Curr Opin Cardiol 18 (2003) 6
4. Passman R., and Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 85 (2001) 321
5. Yap Y.G., and Camm A.J. Drug induced QT prolongation and torsade de pointes. Heart 89 (2003) 1363
6. Roden D.M. Drug-induced prolongation of the QT interval. N Engl J Med 350 (2004) 1013